Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Sensors (Basel) ; 21(12)2021 Jun 17.
Article in English | MEDLINE | ID: mdl-34204235

ABSTRACT

To achieve good performance, athletes need to synchronize a series of movements in an optimal manner. One of the indicators used to monitor this is the order of occurrence of relevant events in the movement timeline. However, monitoring of this characteristic of rapid movement is practically limited to the laboratory settings, in which motion tracking systems can be used to acquire relevant data. Our motivation is to implement a simple-to-use and robust IMU-based solution suitable for everyday praxis. In this way, repetitive execution of technique can be constantly monitored. This provides augmented feedback to coaches and athletes and is relevant in the context of prevention of stabilization of errors, as well as monitoring for the effects of fatigue. In this research, acceleration and rotational speed signal acquired from a pair of IMUs (Inertial Measurement Unit) is used for detection of the time of occurrence of events. The research included 165 individual strikes performed by 14 elite and national-level karate competitors. All strikes were classified as slow, average, or fast based on the achieved maximal velocity of the hand. A Kruskal-Wallis test revealed significant general differences in the order of occurrence of hand acceleration start, maximal hand velocity, maximal body velocity, maximal hand acceleration, maximal body acceleration, and vertical movement onset between the groups. Partial differences were determined using a Mann-Whitney test. This paper determines the differences in the temporal structure of the reverse punch in relation to the achieved maximal velocity of the hand as a performance indicator. Detecting the time of occurrence of events using IMUs is a new method for measuring motion synchronization that provides a new insight into the coordination of articulated human movements. Such application of IMU can provide additional information about the studied structure of rapid discrete movements in various sporting activities that are otherwise imperceptible to human senses.


Subject(s)
Acceleration , Movement , Athletes , Biomechanical Phenomena , Humans , Motion
2.
Histopathology ; 62(4): 543-50, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23398044

ABSTRACT

AIMS: The majority of adenoid cystic carcinomas (AdCCs), regardless of anatomical site, harbour the MYB-NFIB fusion gene. The aim of this study was to characterize the repertoire of somatic genetic events affecting known cancer genes in AdCCs. METHODS AND RESULTS: DNA was extracted from 13 microdissected breast AdCCs, and subjected to a mutation survey using the Sequenom OncoCarta Panel v1.0. Genes found to be mutated in any of the breast AdCCs and genes related to the same canonical molecular pathways, as well as KIT, a proto-oncogene whose protein product is expressed in AdCCs, were sequenced in an additional 68 AdCCs from various anatomical sites by Sanger sequencing. Using the Sequenom MassARRAY platform and Sanger sequencing, mutations in BRAF and HRAS were identified in three and one cases, respectively (breast, and head and neck). KIT, which has previously been reported to be mutated in AdCCs, was also investigated, but no mutations were identified. CONCLUSIONS: Our results demonstrate that mutations in genes pertaining to the canonical RAS pathway are found in a minority of AdCCs, and that activating KIT mutations are either absent or remarkably rare in these cancers, and unlikely to constitute a driver and therapeutic target for patients with AdCC.


Subject(s)
Breast Neoplasms/genetics , Carcinoma, Adenoid Cystic/genetics , Head and Neck Neoplasms/genetics , Lung Neoplasms/genetics , Mutation/genetics , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins p21(ras)/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Carcinoma, Adenoid Cystic/metabolism , Carcinoma, Adenoid Cystic/pathology , DNA Mutational Analysis/methods , Female , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Proto-Oncogene Mas , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins B-raf/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Proto-Oncogene Proteins p21(ras)/metabolism
3.
Rheumatology (Oxford) ; 51(1): 120-8, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22072084

ABSTRACT

OBJECTIVE: To investigate the construct validity and reliability of US DAS compared with 28-joint DAS (DAS-28) in assessing joint inflammation and in prediction of structural damage in patients with RA. METHODS: Ninety patients with active RA were prospectively recruited and followed up during the 6 months of treatment. The patients underwent clinical, laboratory and X-ray assessment, along with blinded power Doppler US (PDUS) and grey-scale (GS) US (GSUS) examination at baseline and 6 months. A subgroup of 25/90 randomly assigned patients underwent MRI examination of their hands at baseline. A PDUS examination of 22 joints and GSUS examination for effusion/hypertrophy (E/H) of 28 joints were performed by two independent examiners, blinded to clinical findings. E/H was qualitatively assessed as absent or present, and PD signal was semi-quantitatively graded from 0 to 3. PDUS score for synovitis in 22 joints and GS score for E/H in 28 joints were included in US DAS calculation. Clinical scoring, PDUS and GSUS inter-observer reliability were evaluated. RESULTS: Strong correlation was found between US DAS and standard assessment of disease activity such as the DAS-28, ESR and CRP levels. Correlation between US DAS and patients' and physicians' visual analogue scale of activity was moderate, whereas correlations of US DAS with Health Assessment Questionnaire - Disability Index (HAQ-DI) and Short Form 36 Health Survey (SF-36) were weak to moderate. US DAS correlated with X-ray, MRI and US parameters and rates of joint damage. CONCLUSION: US DAS better anticipated future joint damage than standard DAS-28.


Subject(s)
Arthritis, Rheumatoid/diagnostic imaging , Severity of Illness Index , Adult , Aged , Aged, 80 and over , Arthritis, Rheumatoid/diagnosis , Disease Progression , Epidemiologic Methods , Humans , Magnetic Resonance Imaging/methods , Metacarpophalangeal Joint/pathology , Middle Aged , Observer Variation , Physical Examination/methods , Prognosis , Synovitis/diagnosis , Synovitis/diagnostic imaging , Ultrasonography, Doppler/methods , Wrist Joint/pathology
4.
Balkan Med J ; 34(3): 278-280, 2017 May 05.
Article in English | MEDLINE | ID: mdl-28443578

ABSTRACT

BACKGROUND: Secondary tumours of the hyoid bone and thyroid cartilage are extremely rare. In this paper, we present a case of the hyoid bone and thyroid cartilage metastases in a patient treated for sigmoid colon adenocarcinoma. CASE REPORT: Four years after sigmoid colon adenocarcinoma was diagnosed and treated with surgery and chemotherapy, the patient developed bone metastases in the left sacroiliac joint and right proximal humerus. Although the patient did not complain of any related symptoms, in a bone scintigraphy the accumulation of Technetium-99m was incidentally detected in the two sites of the anterior neck. On ultrasound examination there were two hyperechoic and heterogeneous masses with calcifications placed in front of the hyoid bone and thyroid cartilage. Computerized tomography demonstrated massive hyoid bone and thyroid cartilage destruction. CONCLUSION: In patients with progressive sigmoid colon adenocarcinoma, destruction of the hyoid bone and thyroid cartilage could be suspected for metastases.


Subject(s)
Hyoid Bone/pathology , Neoplasm Metastasis/physiopathology , Sigmoid Neoplasms/complications , Thyroid Neoplasms/etiology , Adenocarcinoma/complications , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Drug Therapy/methods , Humans , Hyoid Bone/diagnostic imaging , Male , Middle Aged , Neoplasm Metastasis/pathology , Sigmoid Neoplasms/surgery , Thyroid Cartilage/diagnostic imaging , Thyroid Cartilage/pathology , Tomography, X-Ray Computed/methods , Ultrasonography/methods
5.
Oncotarget ; 8(4): 6057-6066, 2017 Jan 24.
Article in English | MEDLINE | ID: mdl-28002809

ABSTRACT

PURPOSE: To determine if models of ovarian clear cell carcinomas (OCCCs) harbouring defects in homologous recombination (HR) DNA repair of double strand breaks (DSBs) are sensitive to cisplatin and/or PARP inhibition. EXPERIMENTAL DESIGN: The HR status of 12 OCCC cell lines was determined using RAD51/γH2AX foci formation assays. Sensitivity to cisplatin and the PARP inhibitor BMN-673 was correlated with HR status. BRCA1, BRCA2, MRE11 and PTEN loss of expression was investigated as a potential determinant of BMN-673 sensitivity. A tissue microarray containing 50 consecutive primary OCCC was assessed for PTEN expression using immunohistochemistry. RESULTS: A subset of OCCC cells displayed reduced RAD51 foci formation in the presence of DNA DSBs, suggestive of HR defects. HR-defective OCCC cells, with the exception of KOC-7c, had higher sensitivity to cisplatin/ BMN-673 than HR-competent OCCC cell lines (Log10 SF50 -9.4 (SD +/- 0.29) vs -8.1 (SD +/- 0.35), mean difference 1.3, p < 0.01). Of the cell lines studied, two, TOV-21G and KOC-7c, showed loss of PTEN expression. In primary OCCCs, loss of PTEN expression was observed in 10% (5/49) of cases. CONCLUSIONS: A subset of OCCC cells are sensitive to PARP inhibition in vitro, which can be predicted by HR defects as defined by γH2AX/RAD51 foci formation. These results provide a rationale for the testing of HR deficiency and PARP inhibitors as a targeted therapy in a subset of OCCCs.


Subject(s)
Cisplatin/pharmacology , DNA Breaks, Double-Stranded , Ovarian Neoplasms/genetics , Phthalazines/pharmacology , Poly(ADP-ribose) Polymerase Inhibitors/pharmacology , BRCA1 Protein/genetics , BRCA2 Protein/genetics , Cell Line, Tumor , DNA Repair , Drug Screening Assays, Antitumor , Female , Humans , MRE11 Homologue Protein/genetics , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/enzymology , PTEN Phosphohydrolase/genetics , PTEN Phosphohydrolase/metabolism , Tissue Array Analysis
6.
Med Pregl ; 63(7-8): 575-8, 2010.
Article in English | MEDLINE | ID: mdl-21443156

ABSTRACT

Multiple organ procurement is a surgical procedure by which organs of a brain dead donor are taken for transplantation. Cadaveric organ donors must be those who have suffered a sudden structural and irreversible damage of the brain or brainstem. Social and scientific aspects of organ transplantation have been widely discussed so far, whereas the religious factor, which should be also respected, has rarely been analyzed. Considering the fact that Serbia is a multicultural and multi-confessional society, opinions of all confessions practised in the Republic of Serbia should be taken into account. The Orthodox Church permits transplantation from one man to another and transplantation is strongly recommended from the standpoint of Christian morality. These attitudes are accepted and respected by the Roman Catholic Church, Reformers, Judaism and Islam as well. For the future development of organ transplantation it is necessary to have a sufficient number of organ donors. Valid and complete laws must strictly define brain death, organ donation and waiting lists. The public should be fully informed about this issue in order to build mutual confidence between the population and medical staff.


Subject(s)
Brain Death , Religion and Medicine , Tissue and Organ Procurement/legislation & jurisprudence , Humans , Serbia , Tissue and Organ Procurement/ethics
SELECTION OF CITATIONS
SEARCH DETAIL